P B F
1 feb, 2022

Genetic Testing for Diagnosis and Management of Mental Health Conditions

Effective 1 de abril de 2022, the criteria used for medical necessity review of GeneSight Psychotropic panel for Medicare Advantage plans will be updated. Please refer to the draft medical policy for details here.